Everolimus in patients with advanced pancreatic neuroendocrine tumors (pNET): Updated results of a randomized, double-blind, placebo-controlled, multicenter, phase III trial (RADIANT-3).
Jonathan Strosberg
Consultant or Advisory Role - Novartis
Research Funding - Novartis
Jeremie Lincy
Employment or Leadership Position - Novartis
Robert Winkler
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Edward Wolin
Consultant or Advisory Role - Novartis